PRCT — Procept Biorobotics Corp · rev $177.6M

Procept Biorobotics Corp (PRCT) is a medical devices company listed on US.

Latest reported PRCT revenue for 2026-06-30 was $177.6M. Net income was -$58.5M. PRCT currently screens at market cap $1.52B.

Use this PRCT page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the PRCT quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the PRCT SEC filings page. Lician reads the product cache first so this HTML stays unique to Procept Biorobotics Corp even when a live quote feed is slow.

Procept Biorobotics Corp latest statements (FY2025)

Latest cached year on this hub. Full PRCT income, balance, and cash tables.

  • Revenue$308.1M
  • Net Income-$95.6M
  • Total Assets$508.1M
  • Total Debt$0
  • Free Cash Flow-$58.3M